Details of the Drug

General Information of Drug (ID: DMCK3OI)

• Drug Name: FT-7051

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 1	[1]

• Cross-matching ID:
  PubChem CID: 138472434
  TTD ID: DT8IL6

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
CREB-binding protein (CREBBP)	TTFRCTK	CBP_HUMAN	Inhibitor	[2]
Histone acetyltransferase p300 (EP300)	TTGH73N	EP300_HUMAN	Inhibitor	[2]

References

• [1] ClinicalTrials.gov (NCT04575766) A Study of FT-7051 in Men With MCRPC. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of FORMA Therapeutics.